Picard Medical (PMI) will participate in the inaugural “Hands-On Training Day” at the Technology and Heart Failure Therapeutics 2026 conference to be held in Boston on March 1st 2026. This interactive, case-based program hosted for the first time at the conference will bring together leading clinicians and innovators to advance education in temporary and durable mechanical circulatory support, hemodynamic monitoring, and the management of cardiogenic shock. Through hands-on training and real-world clinical scenarios, the program is designed to strengthen multidisciplinary collaboration among practitioners and improve patient outcomes in advanced heart failure. Stephen Zamojski, Head of Global Sales and Clinical Education at SynCardia Systems, commented, “As adoption of total artificial heart therapy continues to expand, education and hands-on familiarity are critical. By engaging directly with the technology in a collaborative setting, clinicians can deepen their understanding of how the SynCardia Total Artificial Heart supports patients through the most advanced stages of heart failure. Our participation in the inaugural Hands-On Training Day at THT 2026 follows the successful SynCardia Training Village held in Houston earlier this week and reflects a key component of our commercial expansion strategy. We remain focused on building strong clinical partnerships, expanding global awareness, and ensuring that leading heart failure centers are equipped to deliver this life-saving therapy.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMI:
- Picard Medical Inc. Investors Face Significant Losses as Lawsuit Alleged Social-Media Stock Promotion Scheme
- Picard Medical to host ‘SynCardia Total Artificial Heart Training Village’
- Picard Medical Facing Investor Suit Over Alleged Stock Promotion Scheme
- Picard Medical announces UCSF performed heart transplant using SynCardia heart
- Picard Medical Launches Cruxx Podcast Highlighting Artificial Heart
